Catalyst
Slingshot members are tracking this event:
PharmaMar submits MAA to EMA for Aplidin for the treatment of multiple myeloma
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
PHM.MC | Community voting in process |
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 22, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Aplidin, Plitidepsin, Dexamethasone, Relapsed/refractory Multiple Myeloma, Admyre Clinical Trial